Latest AstraZeneca Stories
LONDON, February 6, 2013 /PRNewswire/ -- Mike Mack, Chief Executive of Swiss agri-business Syngenta, is interviewed on the full year results for 2012. Mr Mack comments on the performance of the company as well as giving an update on the business integration and discussing the outlook. The interview is available now on http://video.merchantcantos.com. MerchantCantos produces in-depth interviews, documentaries and webcasts with senior company executives. If you...
BASEL, Switzerland, Feb. 6, 2013 /PRNewswire/ -- Syngenta announced today that the Board will propose the election of two new directors, Eleni Gabre-Madhin and Eveline Saupper, at the Annual General Meeting on April 23, 2013. In addition to the Chairman, Martin Taylor, three current directors - Peggy Bruzelius, Peter Thompson and Felix Weber - will retire on the same date, having completed their terms of office. The Board will also propose the re-election of Michael Mack and of...
BASEL, Switzerland, Feb. 6, 2013 /PRNewswire/ -- Annual capacity to be quadrupled Driven by grower demand for leading corn hybrids Enabling expansion of integrated corn solutions Syngenta today announced plans to invest $77 million in the expansion of its corn seed production facility in Formosa, Brazil. Annual capacity will be quadrupled to 1.6 million bags by 2015. Corn production in Brazil is expected to almost double by 2020, spurred by growth in the pork and poultry...
BASEL, Switzerland, Feb. 6, 2013 /PRNewswire/ -- Sales $14.2 billion, up 7 percent; up 10 percent at constant exchange rates (CER)(1) strong fourth quarter in North and Latin America double digit Seeds growth in all regions (CER) EBITDA up 17 percent at CER Net income $1.9 billion, up 17 percent Earnings per share(2) $22.30, up 15 percent Free cash flow before record level of acquisitions: $0.9 billion Proposed dividend increased by 19 percent to CHF 9.50...
LONDON, January 28, 2013 /PRNewswire/ -- Avillion LLP, which focuses on clinical co-development of therapeutics, today announced that it has received initial funding from Abingworth LLP and Clarus Ventures. Avillion, based in London, UK, is partnering with pharmaceutical and biotechnology companies to co-developand finance latestage therapeutics. The company will use its clinical development and regulatory expertise to obtain global approvalsfor a broad range of drugs...
The law firm of d’Oliveira & Associates is working with some of the leading Prilosec lawyers in the country handling Prilosec cases and want the public to know that they offer a “No Win No Fee Promise” for Prilosec users who have suffered osteoporosis-like bone fractures in the wrist, hip, spine, etc. This means that you would pay no legal fee unless and until you receive a settlement or award of your Prilosec claim and/or Prilosec lawsuit. (PRWEB) January 18, 2013 Originally...
Lee Rannals for redOrbit.com – Your Universe Online A new flu vaccine won regulatory approval on Wednesday and its limited supplies are expected to be available this winter. Protein Sciences won the approval for Flublok, which is made with a process that does not require the virus to be grown in chicken eggs. “This approval represents a technological advance in the manufacturing of an influenza vaccine,” Dr. Karen Midthun, a senior official at the U.S. Food and Drug...
NIH researcher assists in study of Norwegian women Norwegian pregnant women who received a vaccine against the 2009 H1N1 influenza virus showed no increased risk of pregnancy loss, while pregnant women who experienced influenza during pregnancy had an increased risk of miscarriages and still births, a study has found. The study suggests that influenza infection may increase the risk of fetal loss. Scientists at the U.S. National Institutes of Health and the Norwegian Institute of Public...
BASEL, Switzerland, Jan. 17, 2013 /PRNewswire/ -- Syngenta today launched a landmark e-licensing platform to provide plant breeders and research institutes around the world with quick and easy access to patented native traits from its commercial vegetable varieties. The global internet-based platform also offers access to patented enabling technologies, which help breeders with gene expression, plant transformation and protein targeting as they develop high-yielding...
Syngenta Biotechnology Signs License Agreement with Plant Sensory Systems to Evaluate their NUEST technology in Sugarcane and Rice Baltimore, MD (PRWEB) January 08, 2013 Plant Sensory Systems, LLC announced today that Syngenta Biotechnology, Inc. has signed an exclusive license agreement to evaluate Plant Sensory Systems’ proprietary Nitrogen Use Efficiency and Stress Tolerance (NUEST) technology in sugarcane and rice. Nitrogen fertilizer, which is critical for the growth, yield, and...
